Detalhe da pesquisa
1.
Revitalising cancer trials post-pandemic: time for reform.
Br J Cancer
; 128(8): 1409-1414, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36959378
2.
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer.
Br J Cancer
; 129(1): 38-45, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37120671
3.
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer.
Br J Cancer
; 128(2): 245-254, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36352028
4.
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 study.
Cancer
; 127(24): 4585-4593, 2021 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34415578
5.
First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor.
Br J Cancer
; 123(4): 525-533, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32523090
6.
Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study.
BMC Cancer
; 19(1): 858, 2019 Aug 29.
Artigo
Inglês
| MEDLINE | ID: mdl-31464604
7.
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial.
Lancet Oncol
; 19(7): 940-952, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29875066
8.
Lenvatinib: a potential breakthrough in advanced hepatocellular carcinoma?
Future Oncol
; 12(4): 465-76, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26785762
9.
Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells.
Immunopharmacol Immunotoxicol
; 38(1): 50-60, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26473647
10.
Hepatocellular Carcinoma as a Complication of Vascular Disease of the Liver After Fontan Procedure.
Hepatology
; 69(2): 911-913, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30055116
11.
Tubulin ß-III: a novel immunohistochemical marker for intrahepatic peripheral cholangiocarcinoma.
Histopathology
; 65(6): 784-92, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25039376
12.
The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours.
J Neuroendocrinol
; 36(4): e13376, 2024 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38389192
13.
Neuroendocrine neoplasms: Consensus on a patient care pathway.
J Neuroendocrinol
; 36(4): e13380, 2024 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38471798
14.
PAK4 pathway as a potential therapeutic target in pancreatic cancer.
Future Oncol
; 14(7): 579-582, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29508632
15.
Next-generation sequencing and molecular therapy.
Clin Med (Lond)
; 23(1): 65-69, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36697006
16.
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer.
Clin Cancer Res
; 29(2): 331-340, 2023 01 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36378548
17.
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma.
EClinicalMedicine
; 60: 102015, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37287870
18.
CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells.
Sci Adv
; 9(42): eadi0244, 2023 10 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37851808
19.
"We'll starve to death": The consequences of COVID-19 over the lives of poor people with disabilities in rural Nepal.
Asian Soc Work Policy Rev
; 16(2): 96-103, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35664839
20.
USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer.
Nat Commun
; 13(1): 2070, 2022 04 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35440539